Your Location:
Home >
Browse articles >
Investigation on Pharmacodynamic Material Basis of Linggui Zhugan Granules for Metabolic Associated Steatohepatitis Based on UPLC-Q-TOF-MS/MS
Updated:2026-08-06
    • Investigation on Pharmacodynamic Material Basis of Linggui Zhugan Granules for Metabolic Associated Steatohepatitis Based on UPLC-Q-TOF-MS/MS

      Enhanced Publication
    • “The research team used UPLC-Q-TOF-MS/MS technology to identify 83 chemical components in Linggui Zhugan granules, established a "compound disease component target" network analysis system, and verified the pharmacological mechanism of flavonoids and terpenoids in treating metabolic related steatohepatitis by regulating the AMPK/SIRT1/PPAR α signaling pathway, opening up a new direction for the research on the pharmacological substance basis of traditional Chinese medicine compound.”
    • YAO Chiyan , LI Liang , YAN Ming , WANG Zhenzhong , ZHANG Chenfeng , LI Ming , XIE Xue
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 17, Pages: 228-238(2026)
    • DOI: 10.13422/j.cnki.syfjx.20260462     

      CLC:
    • Revised:2026-03-31 ,

      Accepted:20 April 2026 ,

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 3 ) Tabs( 5 )

  • References

  • Publication Info

  • Metrics

149

Views

88

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Maillard Reaction in Processing of Traditional Chinese Medicine: A Review
"Medicinal Part-Habitat-Tissue-Component" Correlations of Aquatic Chinese Medicinal Plants
Qualitative and Quantitative Analysis of Chemical Constituents in Liu Junzitang by UPLC-Q-TOF-MS/MS and UPLC
Identification of Traditional Chinese Medicine Seahorses Using Graphene Oxide-based Fluorescent Sensing Technology
Molecular Mechanisms and Research Progress of Traditional Chinese Medicine Intervention in Diabetic Foot Ulcers Based on Regulation of Inflammation-oxidative Stress Axis

Related Author

YAO Chiyan
WANG Zhenzhong
WANG Kai
QU Zhenni
BI Yu
SHI Dianhua
DAI Yanpeng
CHEN Lin

Related Institution

State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture,Jiangsu Kanion Pharmaceutical Co. Ltd. Nanjing University of Chinese Medicine
Shandong University of Traditional Chinese Medicine
Shandong Academy of Chinese Medicine
Henan Key Laboratory of Traditional Chinese Medicine Resources and Chemistry
School of Pharmacy,Henan University of Chinese Medicine